Central effects of endogenous progesterone and synthetic progestational agents.
D000085:Acetates / Q000494:pharmacology*; D000328:Adult; D000818:Animals; D002208:Caproates / Q000494:pharmacology*; D002369:Castration; D003864:Depression, Chemical; D004412:Dysmenorrhea / Q000188:drug therapy; D005260:Female; D005640:Follicle Stimulating Hormone / Q000037:antagonists & inhibitors; D006062:Gonadotropins / Q000652:urine*; D006168:Guinea Pigs; D006801:Humans; D006984:Hypertrophy / Q000139:chemically induced; D007986:Luteinizing Hormone / Q000037:antagonists & inhibitors; D009640:Norethindrone / Q000494:pharmacology*; D009929:Organ Size; D010053:Ovary / Q000601:surgery; D010060:Ovulation / Q000187:drug effects*; D011374:Progesterone / Q000494:pharmacology*; D011372:Progestins / Q000008:administration & dosage* / Q000627:therapeutic use; D011388:Prolactin / Q000037:antagonists & inhibitors; D013154:Spleen / Q000601:surgery; D013268:Stimulation, Chemical; D013997:Time Factors; D014599:Uterus / Q000033:anatomy & histology
D000085:Acetates; D002208:Caproates; D006062:Gonadotropins; D011372:Progestins; D011374:Progesterone; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D009640:Norethindrone